Horan Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.12M Sell
13,212
-20
-0.2% -$5.91K 1.39% 22
2024
Q4
$3.45M Buy
13,232
+310
+2% +$92K 1.16% 25
2024
Q3
$4.16M Sell
12,922
-226
-2% -$73.9K 1.38% 21
2024
Q2
$4.11M Sell
13,148
-87
-0.7% -$25.6K 1.44% 20
2024
Q1
$3.76M Sell
13,235
-99
-0.7% -$29K 1.34% 25
2023
Q4
$3.84M Sell
13,334
-604
-4% -$165K 1.41% 23
2023
Q3
$3.75M Sell
13,938
-255
-2% -$63.6K 1.51% 23
2023
Q2
$3.15M Buy
14,193
+129
+0.9% +$29.9K 1.23% 28
2023
Q1
$3.4M Buy
+14,064
New +$3.45M 1.4% 26
2020
Q4
Sell
-562
Closed -$143K 93
2020
Q3
$143K Buy
+562
New +$139K 0.08% 95
2020
Q1
Sell
-572
Closed -$138K 80
2019
Q4
$138K Sell
572
-2
-0.3% -$441 0.08% 89
2019
Q3
$111K Buy
+574
New +$110K 0.07% 92
2019
Q2
Sell
-549
Closed -$104K 80
2019
Q1
$104K Buy
+549
New +$105K 0.07% 98
2017
Q4
Sell
-807
Closed -$150K 77
2017
Q3
$150K Buy
+807
New +$143K 0.09% 80
2016
Q1
Sell
-1,235
Closed -$200K 59
2015
Q4
$200K Buy
+1,235
New +$194K 0.17% 58
2014
Q3
Sell
-1,705
Closed -$202K 58
2014
Q2
$202K Hold
1,705
0.18% 65
2014
Q1
$210K Sell
1,705
-239
-12% -$29K 0.2% 67
2013
Q4
$222K Buy
+1,944
New +$221K 0.23% 62

Other funds holding AMGN

Horan Capital Advisors's AMGN Position: Q1 2025 in Review

Horan Capital Advisors reduced its Amgen (AMGN) stake by 0.15% in Q1 2025, selling an estimated $5.91K and leaving 13,212 shares worth $4.12M. The position accounts for 1.39% of the portfolio, ranked #22.

Horan Capital Advisors first reported a position in AMGN in Q4 2013 and has held it in 18 quarters since. The position peaked at $4.16M in Q3 2024. 2,928 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Horan Capital Advisors held 13,212 shares of Amgen worth $4.12M as of Q1 2025.
  • Horan Capital Advisors sold 20 Amgen shares in Q1 2025, an estimated $5.91K.
  • Amgen made up 1.39% of Horan Capital Advisors's portfolio in Q1 2025, its #22 holding.
  • Horan Capital Advisors first reported a position in Amgen in Q4 2013 and has held it in 18 quarters since.
  • Horan Capital Advisors's Amgen position peaked at $4.16M in Q3 2024.
  • 2,928 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Horan Capital Advisors's 13F filing for Q1 2025, filed 7 May 2025.